McKnight's Long-Term Care News17h
FDA approves gepotidacin antibiotic for uncomplicated urinary tract infections
The Food and Drug Administration has approved a new antibiotic that can treat uncomplicated urinary tract infections, or ...
Can GSK's Blujepa provide relief from UTIs amid rising bacterial resistance and declining treatment efficacy?
The US Food and Drug Administration (FDA) has early this week approved GSK's new antibiotic, Blujepa (gepotidacin), for the ...
Healio2d
FDA approves first new antibiotic for uncomplicated UTIs in nearly 30 years
The FDA approved gepotidacin for the treatment of uncomplicated UTIs in women and adolescent girls aged 12 years or older, ...
Interesting Engineering on MSN2d
New hope for UTI patients as FDA approves first-of-its-kind antibiotic in 30 years
The U.S. Food and Drug Administration (FDA) has approved a new class of antibiotics for treating uncomplicated urinary tract ...
Medical Dialogues2d
FDA Approves Gepotidacin for Uncomplicated UTIs
The FDA has approved GSK’s gepotidacin (Blujepa) for treating uncomplicated urinary tract infections (uUTIs) in females aged ...
Fierce Pharma3d
GSK ushers in new UTI antibiotic with FDA nod for first-in-class Blujepa
GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...
MPR2d
FDA Approves Blujepa for Uncomplicated UTI in Female Patients
Gepotidacin is an oral, first-in-class triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by blocking 2 different type II topoisomerase enzymes.
FDA Approves GSK's Oral Antibiotic For Urinary Tract Infections For Females Aged 12 Years And Older
The FDA approved GSK's Blujepa for uncomplicated UTIs in female adults and pediatric patients, with phase 3 trials showing strong efficacy vs. nitrofurantoin.
MedPage Today on MSN3d
FDA OKs New Option for Uncomplicated UTIs in Women, Girls
The FDA approved oral gepotidacin (Blujepa) for uncomplicated urinary tract infections (UTIs) in women and girls ages 12 ...
GlobalData on MSN2d
FDA approves GSK’s Blujepa for uncomplicated UTIs
The US Food and Drug Administration (FDA) has approved GSK’s triazaacenaphthylene antibiotic, Blujepa (gepotidacin), for ...
The American Journal of Managed Care2d
FDA Approves First New Class of Oral Antibiotics for Uncomplicated UTIs in Nearly 30 Years
The approval of gepotidacin (Blujepa; GSK) introduces the first new class of oral antibiotics for uncomplicated urinary tract ...
HealthDay on MSN2d
FDA Approves Blujepa for Uncomplicated Urinary Tract Infections
The U.S. Food and Drug Administration has approved Blujepa (gepotidacin) for the treatment of uncomplicated urinary tract ...